276 related articles for article (PubMed ID: 30779222)
1. Functional deficiency in endogenous interleukin-1 receptor antagonist in patients with febrile infection-related epilepsy syndrome.
Clarkson BDS; LaFrance-Corey RG; Kahoud RJ; Farias-Moeller R; Payne ET; Howe CL
Ann Neurol; 2019 Apr; 85(4):526-537. PubMed ID: 30779222
[TBL] [Abstract][Full Text] [Related]
2. Successful Treatment of Pediatric FIRES With Anakinra.
Yang JH; Nataraj S; Sattar S
Pediatr Neurol; 2021 Jan; 114():60-61. PubMed ID: 33227629
[No Abstract] [Full Text] [Related]
3. Febrile Infection-Related Epilepsy Syndrome Treated Successfully With Anakinra in a 21-Year-Old Woman.
Westbrook C; Subramaniam T; Seagren RM; Tarula E; Co D; Furstenberg-Knauff M; Wallace A; Hsu D; Payne E
WMJ; 2019 Oct; 118(3):135-139. PubMed ID: 31682750
[TBL] [Abstract][Full Text] [Related]
4. Febrile infection-related epilepsy syndrome treated with anakinra.
Kenney-Jung DL; Vezzani A; Kahoud RJ; LaFrance-Corey RG; Ho ML; Muskardin TW; Wirrell EC; Howe CL; Payne ET
Ann Neurol; 2016 Dec; 80(6):939-945. PubMed ID: 27770579
[TBL] [Abstract][Full Text] [Related]
5. Proposal to optimize evaluation and treatment of Febrile infection-related epilepsy syndrome (FIRES): A Report from FIRES workshop.
Koh S; Wirrell E; Vezzani A; Nabbout R; Muscal E; Kaliakatsos M; Wickström R; Riviello JJ; Brunklaus A; Payne E; Valentin A; Wells E; Carpenter JL; Lee K; Lai YC; Eschbach K; Press CA; Gorman M; Stredny CM; Roche W; Mangum T
Epilepsia Open; 2021 Mar; 6(1):62-72. PubMed ID: 33681649
[TBL] [Abstract][Full Text] [Related]
6. Anakinra and tocilizumab in the chronic phase of febrile infection-related epilepsy syndrome (FIRES): Effectiveness and safety from a case-series.
Aledo-Serrano A; Hariramani R; Gonzalez-Martinez A; Álvarez-Troncoso J; Toledano R; Bayat A; Garcia-Morales I; Becerra JL; Villegas-Martínez I; Beltran-Corbellini A; Gil-Nagel A
Seizure; 2022 Aug; 100():51-55. PubMed ID: 35759951
[TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of patients with new onset refractory status epilepticus preceded by fever (febrile infection-related epilepsy syndrome) versus without prior fever: An interim analysis.
Jimenez AD; Gopaul M; Asbell H; Aydemir S; Basha MM; Batra A; Damien C; Day GS; Eka O; Eschbach K; Fatima S; Fields MC; Foreman B; Gerard EE; Gofton TE; Haider HA; Hantus ST; Hocker S; Jongeling A; Kalkach Aparicio M; Kandula P; Kang P; Kazazian K; Kellogg MA; Kim M; Lee JW; Marcuse LV; McGraw CM; Mohamed W; Orozco J; Pimentel C; Punia V; Ramirez AM; Steriade C; Struck AF; Taraschenko O; Treister AK; Yoo JY; Zafar S; Zhou DJ; Zutshi D; Gaspard N; Hirsch LJ; Hanin A
Epilepsia; 2024 Jun; 65(6):e87-e96. PubMed ID: 38625055
[TBL] [Abstract][Full Text] [Related]
8. Anakinra usage in febrile infection related epilepsy syndrome: an international cohort.
Lai YC; Muscal E; Wells E; Shukla N; Eschbach K; Hyeong Lee K; Kaliakatsos M; Desai N; Wickström R; Viri M; Freri E; Granata T; Nangia S; Dilena R; Brunklaus A; Wainwright MS; Gorman MP; Stredny CM; Asiri A; Hundallah K; Doja A; Payne E; Wirrell E; Koh S; Carpenter JL; Riviello J
Ann Clin Transl Neurol; 2020 Dec; 7(12):2467-2474. PubMed ID: 33506622
[TBL] [Abstract][Full Text] [Related]
9. Febrile Infection-Related Epilepsy Syndrome (FIRES): An Overview of Treatment and Recent Patents.
Hon KL; Leung AKC; Torres AR
Recent Pat Inflamm Allergy Drug Discov; 2018; 12(2):128-135. PubMed ID: 29745347
[TBL] [Abstract][Full Text] [Related]
10. Second-line immunotherapy in new onset refractory status epilepticus.
Hanin A; Muscal E; Hirsch LJ
Epilepsia; 2024 May; 65(5):1203-1223. PubMed ID: 38430119
[TBL] [Abstract][Full Text] [Related]
11. Towards a Treatment for Neuroinflammation in Epilepsy: Interleukin-1 Receptor Antagonist, Anakinra, as a Potential Treatment in Intractable Epilepsy.
Yamanaka G; Ishida Y; Kanou K; Suzuki S; Watanabe Y; Takamatsu T; Morichi S; Go S; Oana S; Yamazaki T; Kawashima H
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34208064
[TBL] [Abstract][Full Text] [Related]
12. Etiology is the key determinant of neuroinflammation in epilepsy: Elevation of cerebrospinal fluid cytokines and chemokines in febrile infection-related epilepsy syndrome and febrile status epilepticus.
Kothur K; Bandodkar S; Wienholt L; Chu S; Pope A; Gill D; Dale RC
Epilepsia; 2019 Aug; 60(8):1678-1688. PubMed ID: 31283843
[TBL] [Abstract][Full Text] [Related]
13. Febrile infection-related epilepsy syndrome (FIRES) with super-refractory status epilepticus revealing autoimmune encephalitis due to GABA
Caputo D; Iorio R; Vigevano F; Fusco L
Eur J Paediatr Neurol; 2018 Jan; 22(1):182-185. PubMed ID: 29203057
[TBL] [Abstract][Full Text] [Related]
14. Ex vivo interleukin 1 receptor antagonist production on lipopolysaccharide stimulation is associated with rheumatoid arthritis and with joint damage.
de Vries-Bouwstra JK; Goekoop-Ruiterman YP; Wesoly J; Hulsmans HJ; de Craen AJ; Breedveld FC; Dijkmans BA; Allaart CF; Huizinga TW
Ann Rheum Dis; 2007 Aug; 66(8):1033-7. PubMed ID: 17223662
[TBL] [Abstract][Full Text] [Related]
15. Proposed consensus definitions for new-onset refractory status epilepticus (NORSE), febrile infection-related epilepsy syndrome (FIRES), and related conditions.
Hirsch LJ; Gaspard N; van Baalen A; Nabbout R; Demeret S; Loddenkemper T; Navarro V; Specchio N; Lagae L; Rossetti AO; Hocker S; Gofton TE; Abend NS; Gilmore EJ; Hahn C; Khosravani H; Rosenow F; Trinka E
Epilepsia; 2018 Apr; 59(4):739-744. PubMed ID: 29399791
[TBL] [Abstract][Full Text] [Related]
16. Biological role of interleukin 1 receptor antagonist isoforms.
Arend WP; Guthridge CJ
Ann Rheum Dis; 2000 Nov; 59 Suppl 1(Suppl 1):i60-4. PubMed ID: 11053091
[TBL] [Abstract][Full Text] [Related]
17. Cannabidiol as a Potential Treatment for Febrile Infection-Related Epilepsy Syndrome (FIRES) in the Acute and Chronic Phases.
Gofshteyn JS; Wilfong A; Devinsky O; Bluvstein J; Charuta J; Ciliberto MA; Laux L; Marsh ED
J Child Neurol; 2017 Jan; 32(1):35-40. PubMed ID: 27655472
[TBL] [Abstract][Full Text] [Related]
18. New-onset refractory status epilepticus (NORSE) and febrile infection-related epilepsy syndrome (FIRES): State of the art and perspectives.
Gaspard N; Hirsch LJ; Sculier C; Loddenkemper T; van Baalen A; Lancrenon J; Emmery M; Specchio N; Farias-Moeller R; Wong N; Nabbout R
Epilepsia; 2018 Apr; 59(4):745-752. PubMed ID: 29476535
[TBL] [Abstract][Full Text] [Related]
19. Interferon beta stimulates interleukin 1 receptor antagonist production in human articular chondrocytes and synovial fibroblasts.
Palmer G; Mezin F; Juge-Aubry CE; Plater-Zyberk C; Gabay C; Guerne PA
Ann Rheum Dis; 2004 Jan; 63(1):43-9. PubMed ID: 14672890
[TBL] [Abstract][Full Text] [Related]
20. Treatment of new onset refractory status epilepticus/febrile infection-related epilepsy syndrome with tocilizumab in a child and a young adult.
Girardin ML; Flamand T; Roignot O; Abi Warde MT; Mutschler V; Voulleminot P; Guillot M; Dinkelacker V; De Saint-Martin A
Epilepsia; 2023 Jun; 64(6):e87-e92. PubMed ID: 36961094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
